학술논문

Safety and Immunogenicity After a Three-Dose SARS-CoV-2 Vaccine Schedule in Allogeneic Stem Cell Transplant Recipients
Document Type
Article
Source
In: Transplantation and Cellular Therapy. (Transplantation and Cellular Therapy, October 2022, 28(10):706.e1-706.e10)
Subject
Language
English
ISSN
26666367